NR 508 Week 6 PowerPoint Grand Rounds Presentation; Dementia
-
$15.00
| Institution | Chamberlain |
| Contributor | Nichols |
65-year-old Hispanic male visited outpatient clinic, with complaints of gradual cognitive decline, which he reports had started 2 years earlier. He states that he began to make significant mistakes at work, where he had maintained the same position for 14 years. His frequent forgetfulness, along with aggravation in recent memory impairments hampered him from fulfilling his work duties. He reports that apraxia and apathy had started 1 year before his present visit to our clinic, and disorientation to time and person has worsened, making his daily commute between his workplace and home impossible..............................................continue
The patient's history, along with neuroimaging results and cognitive test results all satisfied the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association Alzheimer's (NINCDS-ADRDA) criteria 16 for probable Alzheimer's disease with high level of evidence (Um et al., 2017).
Questions:
- What medications are considered first line treatment for dementia?
- What is a common side effect of Cholinesterase Inhibitors?
- What is a common sign/symptom of Dementia:
- How can Memantine be used in patient with Dementia
- What is the initial starting dose of Mematine?
| Instituition / Term | |
| Term | Session 2019 |
| Institution | Chamberlain |
| Contributor | Nichols |
